Evidence map›Paper›PMID 12559763›Full record

ReviewTrends in pharmacological sciences2003

Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family.

Maria P Abbracchio, Jean-Marie Boeynaems, Eric A Barnard, José L Boyer, Charles Kennedy, Maria Teresa Miras-Portugal, Brian F King, Christian Gachet, Kenneth A Jacobson, Gary A Weisman and 1 more

Open access · greenAbstract readReview
In one paragraph

Review in Trends in pharmacological sciences, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 138 papers.

0numbers the graph read from it
0cells of the map it votes in
138citing papers in PubMed
36.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

138 citing papers in PubMed, 411 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. P2YActa pharmaceutica Sinica. B · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Analysis ofFrontiers in nutrition · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

78 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 11 institutions in 6 countries.

Maria P AbbracchioDepartment of Pharmacological Sciences, University of Milan, Italy.
Jean-Marie Boeynaems
Eric A Barnard
José L Boyer
Charles Kennedy
Maria Teresa Miras-Portugal
Brian F King
Christian Gachet
Kenneth A Jacobson
Gary A Weisman
Geoffrey Burnstock
Inserm · FRInspire Institute · USNational Institutes of Health · USRoland Hill (United Kingdom) · GBThe Royal Free Hospital · GBUniversidad Complutense de Madrid · ESUniversité Libre de Bruxelles · BEUniversity of Cambridge · GBUniversity of Milan · ITUniversity of Missouri · USUniversity of Strathclyde · GB

Funding

PROSTHETIC GROUPS FOR RADIOLABELING OF FUNCTIONALIZED DRUGS AND PEPTIDESZ01DK031116 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI JACOBSON, KENNETH ALAN · 1991 to 2008
$769k
Intramural NIH HHS Z01 DK031116
6 · The paper itself

Abstract

The cloning of a human G-protein-coupled receptor (GPCR) that specifically responds to UDP-glucose and related sugar-nucleotides has been reported recently. This receptor has important structural similarities to known members of the P2Y receptor family but also shows a distinctly different pharmacological response profile. Here, the IUPHAR Subcommittee for P2Y receptor nomenclature and classification review the current knowledge of this receptor and present their reasons for including this receptor in the P2Y receptor family as the P2Y(14) receptor.

Indexed as

Receptors, G-Protein-CoupledAnimalsBinding SitesHumansReceptors, Purinergic P2Receptors, Purinergic P2YUridine Diphosphate GlucoseP2Y14 receptor, humanReceptors, G-Protein-CoupledReceptors, Purinergic P2Receptors, Purinergic P2YUridine Diphosphate Glucose

Identifiers

PMID12559763
PMCPMC8653507
OpenAlexW2050417355

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.